Vivakor, Inc., a transdisciplinary research company that develops and acquires primarily biomedical and electro-optic products, has put together the contacts and technologies to establish a healthy position in what is estimated to be a $1.9 billion marketplace.

The company’s business model is to be a research hub focused on scientific and market needs that are not currently being met. Vivakor’s mission is to advance or acquire technologies that help patients, researchers, clinicians, and consumers, and the company realizes the importance of obtaining and coordinating the best scientific and business support to do this. To this end, it has established key relationships with various collaborative partners, and has developed strong product-specific commercialization strategies. Vivakor will have the necessary partnerships and licensing arrangements in place for each of its products from the very beginning of product conception or acquisition.

This approach has important advantages:

• More efficient research and development • Quicker time to market

...

Companies featured in this edition of the newsletter: CBAI, ICLK, ITUI, IWEB, MBCI, OMCM, SIHI, SRCO

Markets continued their torrid pace this week on the strength of encouraging reports from two of the most beleaguered economic sectors, which led to gains in all of the major indices following the week’s activities. All told, the Dow ended the week up 2.2%, gaining 198 to close at 9370, bringing its YTD gains to 6.8%. The Nasdaq gained 1.1% on the week, bringing its yearly gains to 26.8% while the S&P 500 and Russell 2000 posted gains of 2.3% and 2.28 % respectively, bringing their yearly gains to 11.9% and 14.6%.

Economic news stole the spotlight this week as earnings season wound down, leaving investors with a more definitive picture of the overall state of recovery than in many weeks prior. The good news started early in the week, as the ISM

...

Analysts are starting to pile into the biotech bandwagon now. And for good reason: the AMEX Biotech Index is actually lower today than it was nine years ago.  Translated into investor-speak, the opportunities in biotech today are fantastic.

I’m not a biotech guy, but my fellow analyst Marc Lichtenfeld is, and he writes about them regularly.

Now that Investment U and our sister publication – Smart Profits – are combining forces, you’ll be hearing about the biotech sector from Marc on a regular basis. Nevertheless, there is something that I do know about the healthcare and biotech sector.

All biotech companies – regardless of whether or not they turn out to be a good investment – need laboratory services and equipment. Therefore, it stands to reason that any boom in the biotech sector would drag along these companies for the ride.

Becton Dickson and Company (NYSE: BDX) – a large-cap

...

Becton Dickson and Company (NYSE: BDX): Stock of the Day

by David Fessler, Advisory Panelist

Analysts are starting to pile into the biotech bandwagon now. And for good reason: the AMEX Biotech Index is actually lower today than it was nine years ago.

Translated into investor-speak, the opportunities in biotech today are fantastic. I’m not a biotech guy, but my fellow analyst Marc Lichtenfeld is, and he writes about them regularly.

Now that Investment U and our sister publication – Smart Profits – are combining forces, you’ll be hearing about the biotech sector from Marc on a regular basis. Nevertheless, there is something that I do know about the healthcare and biotech sector.

All biotech companies – regardless of whether or not they turn out to be a good investment – need laboratory services and equipment.

...

Today, businesses around the globe are growing alongside technology. The pace of relaying information seems to increase by the minute, and organizations around the world are rapidly adding devices to their meeting rooms, auditoriums and training facilities, with the intentions of enhancing employee productivity, reducing operating costs, and developing business approaches that are more environmentally conscious.

Simtrol, Inc. (SMRL.OB) is a company focused on helping businesses manage and facilitate numerous devices through one platform. Simtrol’s device management platform enables businesses to control and monitor an advanced suite of devices from a single point. The solution’s streamlined user interface allows for proactive monitoring to ensure asset uptime. It also delivers rich diagnostic tools to enable the IT staff to troubleshoot and repair technical problems that may arise on-site or in remote locations. Whether it’s to manage a single room, an entire building, or

...

SPX Corporation (SPW) boosted its earnings guidance for the second time on strong growth in the second quarter. The company recently posted second-quarter earnings per share of $1.70, exceeding the consensus estimate by 9% and outpacing year-prior total.

Company Description

SPX provides creative solutions that enable its customers to deliver things like the parts and processes necessary to help manufacture food, beverages, pharmaceuticals and other critical products.

The company also provides solutions that help generate the power that heats homes, cools sports venues, transports products and more, as well as solutions that help tap into new energy sources like enabling power generation plants to run on alternate energy sources.

SPX’s businesses market and manufacture products and services for global infrastructure, process equipment and diagnostics tools. The company’s businesses segments are flow technology, test and measurement, thermal equipment and services, and industrial products and services.

...